Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Merck Serono |
Recipient: An Immediate Family Member |
Company: Boehringer Ingelheim |
Recipient: An Immediate Family Member |
Company: Novartis |
Recipient: An Immediate Family Member |
Company: BioNtech |
Recipient: An Immediate Family Member |
Company: Bristol-Myers Squibb/Medarex |
Recipient: An Immediate Family Member |
Company: Merus NV |
Recipient: An Immediate Family Member |
Company: Neogene Therapeutics |
Recipient: An Immediate Family Member |
Company: Tempus |
Recipient: An Immediate Family Member |
Company: Ability Pharma |
Recipient: An Immediate Family Member |
Company: Agenus |
Recipient: An Immediate Family Member |
Company: Alligator Biosciences |
Recipient: An Immediate Family Member |
Company: Astellas |
Recipient: An Immediate Family Member |
Company: Astellas |
Recipient: An Immediate Family Member |
Company: Arcus |
Recipient: An Immediate Family Member |
Company: Fibrogen |
Recipient: An Immediate Family Member |
Company: Moma Therapeutics |
Recipient: An Immediate Family Member |
Company: Regeneron |
Recipient: An Immediate Family Member |
Company: Revolution Medicines |
Recipient: An Immediate Family Member |
Company: Syros |
Recipient: An Immediate Family Member |
Company: Tango |
Recipient: An Immediate Family Member |
Company: Ipsen |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: Yiviva |
Recipient: You |
Company: Roche/Genentech |
Recipient: You |
Company: Autem |
Recipient: You |
Company: Berry Genomics |
Recipient: You |
Company: Vector Health |
Recipient: You |
Company: Servier |
Recipient: You |
Company: J-Pharma |
Recipient: You |
Company: Abbvie |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: AstraZeneca |
Recipient: Your Institution |
Company: Bristol-Myers Squibb |
Recipient: Your Institution |
Company: BioNtech |
Recipient: Your Institution |
Company: Genentech/Roche |
Recipient: Your Institution |
Company: Helsinn |
Recipient: Your Institution |
Company: Yiviva |
Recipient: Your Institution |
Company: Elicio Therapeutics |
Recipient: Your Institution |
Company: Agenus |
Recipient: Your Institution |
Company: Parker Institute for Cancer Immunotherapy |
Recipient: Your Institution |
Company: Pertzye |
Recipient: Your Institution |
Company: Arcus |
Recipient: Your Institution |
Company: Abbvie |
Recipient: Your Institution |
Company: Atara |
Recipient: Your Institution |
Company: Beigene |
Recipient: Your Institution |
Company: Digestive Care |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|